Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma.

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Pubmed

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma.

Download PDF

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma.

Reni, Michele; Zanon, Silvia; Balzano, Gianpaolo; Passoni, Paolo; Pircher, Chiara; Chiaravalli, Marta; Fugazza, Clara; Ceraulo, Domenica; Nicoletti, Roberto; Arcidiacono, Paolo Giorgio; Macchini, Marina; Peretti, Umberto; Castoldi, Renato; Doglioni, Claudio; Falconi, Massimo; Partelli, Stefano; Gianni, Luca
European Journal of Cancer , Volume 102: 8 – Apr 22, 2019

Loading next page...
 
/lp/pubmed/a-randomised-phase-2-trial-of-nab-paclitaxel-plus-gemcitabine-with-or-a2LvUsxI8s

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0959-8049
DOI
10.1016/j.ejca.2018.07.007
pmid
30149366

Abstract

Journal

European Journal of Cancer – Pubmed

Published: Apr 22, 2019

There are no references for this article.